Sovenyr Get early access

Signal2026-05-25

NIH RePORTER

Repurposing esomeprazole for the treatment of scleroderma

Part of

Phase 2 Clinical Trial Developments

Open primary source See the whole picture

Powered by Sovenyr — cross-source signal intelligence. Figures are collected data as-dated, not investment advice.